{"id":"https://openalex.org/W64777026","doi":null,"title":"Effects of midazolam and buspirone on in vivo concentration of amino acids and monoamine metabolites in the rat hippocampus.","display_name":"Effects of midazolam and buspirone on in vivo concentration of amino acids and monoamine metabolites in the rat hippocampus.","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W64777026","mag":"64777026","pmid":"https://pubmed.ncbi.nlm.nih.gov/18443382"},"language":"en","primary_location":{"id":"pmid:18443382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18443382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050919123","display_name":"Aleksandra Wis\u0142owska-Stanek","orcid":"https://orcid.org/0000-0001-5657-1089","observed_orcids":["https://orcid.org/0000-0001-5657-1089"]},"institutions":[{"id":"https://openalex.org/I268303160","display_name":"Medical University of Warsaw","ror":"https://ror.org/04p2y4s44","country_code":"PL","type":"education","lineage":["https://openalex.org/I268303160"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Aleksandra Wis\u0142owska-Stanek","raw_affiliation_strings":["Department of Experimental and Clinical Pharmacology, Medical University, Krakowskie Przedmie\u015bcie 26/28, PL 00-927 Warszawa, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental and Clinical Pharmacology, Medical University, Krakowskie Przedmie\u015bcie 26/28, PL 00-927 Warszawa, Poland","institution_ids":["https://openalex.org/I268303160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073429756","display_name":"Adam Hamed","orcid":"https://orcid.org/0000-0003-1477-9177","observed_orcids":["https://orcid.org/0000-0003-1477-9177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Hamed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037770026","display_name":"Ma\u0142gorzata Lehner","orcid":"https://orcid.org/0000-0003-2154-8422","observed_orcids":["https://orcid.org/0000-0003-2154-8422"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ma\u0142gorzata Lehner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037307431","display_name":"Andrzej Bidzi\u0144ski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrzej Bidzi\u0144ski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068040501","display_name":"Danuta Turzy\u0144ska","orcid":"https://orcid.org/0000-0001-5183-1435","observed_orcids":["https://orcid.org/0000-0001-5183-1435"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danuta Turzy\u0144ska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022626671","display_name":"Alicja Sobolewska","orcid":"https://orcid.org/0000-0002-8625-6466","observed_orcids":["https://orcid.org/0000-0002-8625-6466"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alicja Sobolewska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103411304","display_name":"Jerzy Walkowiak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerzy Walkowiak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077298898","display_name":"Adam P\u0142a\u017anik","orcid":"https://orcid.org/0000-0002-4263-9836","observed_orcids":["https://orcid.org/0000-0002-4263-9836"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam P\u0142a\u017anik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.125,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.4201929,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"60","issue":"2","first_page":"209","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6234999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6234999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.3666999936103821,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10448","display_name":"Memory and Neural Mechanisms","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":0.9800000190734863},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":1.0},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.925000011920929},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.8930000066757202},{"id":"https://openalex.org/keywords/gaba","display_name":"GABA","score":0.9739999771118164},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/dopamine-metabolites","display_name":"dopamine metabolites","score":0.9610000252723694},{"id":"https://openalex.org/keywords/5-hydroxyindoleacetic-acid","display_name":"5-hydroxyindoleacetic acid","score":0.9559999704360962},{"id":"https://openalex.org/keywords/homovanillic-acid","display_name":"homovanillic acid","score":0.9679999947547913},{"id":"https://openalex.org/keywords/dopac","display_name":"DOPAC","score":0.9470000267028809},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8700000047683716},{"id":"https://openalex.org/keywords/fear-conditioning","display_name":"fear conditioning","score":0.8379999995231628},{"id":"https://openalex.org/keywords/freezing-response","display_name":"freezing response","score":0.7609999775886536},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8420000076293945},{"id":"https://openalex.org/keywords/azapirones","display_name":"azapirones","score":0.9539999961853027},{"id":"https://openalex.org/keywords/extracellular-amino-acids","display_name":"extracellular amino acids","score":0.6549999713897705},{"id":"https://openalex.org/keywords/monoamine-metabolites","display_name":"monoamine metabolites","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C2775841634","wikidata":"https://www.wikidata.org/wiki/Q903566","display_name":"Homovanillic acid","level":4,"score":0.9233394265174866},{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.9132360816001892},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6566945910453796},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.64568692445755},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6428287029266357},{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.6253567934036255},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6007694602012634},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.580100953578949},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.48404496908187866},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.46675729751586914},{"id":"https://openalex.org/C2775905480","wikidata":"https://www.wikidata.org/wiki/Q4634071","display_name":"3,4-Dihydroxyphenylacetic acid","level":5,"score":0.4642292857170105},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4526784121990204},{"id":"https://openalex.org/C148762608","wikidata":"https://www.wikidata.org/wiki/Q3748185","display_name":"Hippocampal formation","level":2,"score":0.41195663809776306},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.3429393470287323},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.329384982585907},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2323569357395172},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17428231239318848},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15837544202804565},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07658195495605469},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004644","descriptor_name":"Emotions","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005110","descriptor_name":"Extracellular Space","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005110","descriptor_name":"Extracellular Space","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005239","descriptor_name":"Fear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006719","descriptor_name":"Homovanillic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006897","descriptor_name":"Hydroxyindoleacetic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015102","descriptor_name":"3,4-Dihydroxyphenylacetic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015306","descriptor_name":"Biogenic Monoamines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:18443382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18443382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1972669181","https://openalex.org/W1980860720","https://openalex.org/W1986853673","https://openalex.org/W1991533097","https://openalex.org/W1991543565","https://openalex.org/W1994808302","https://openalex.org/W1995387616","https://openalex.org/W1999684873","https://openalex.org/W2003983445","https://openalex.org/W2013052579","https://openalex.org/W2014931064","https://openalex.org/W2021087112","https://openalex.org/W2027709174","https://openalex.org/W2042122110","https://openalex.org/W2043603069","https://openalex.org/W2043754658","https://openalex.org/W2056774966","https://openalex.org/W2073117914","https://openalex.org/W2087186617","https://openalex.org/W2087796353","https://openalex.org/W2092908224","https://openalex.org/W2133352477","https://openalex.org/W2163815564","https://openalex.org/W2233987578","https://openalex.org/W2408557049","https://openalex.org/W2409263872","https://openalex.org/W2412835714","https://openalex.org/W2415976451","https://openalex.org/W2418541272"],"related_works":["https://openalex.org/W1994164430","https://openalex.org/W2065708760","https://openalex.org/W2415591749","https://openalex.org/W7099862026","https://openalex.org/W2014371004","https://openalex.org/W1955037372","https://openalex.org/W2070104718","https://openalex.org/W2086589099","https://openalex.org/W2070051797","https://openalex.org/W1995976417"],"abstract_inverted_index":{"The":[0,123],"effects":[1,137],"of":[2,5,18,40,60,68,78,89,115,132,138],"anxiolytic":[3,139],"doses":[4],"buspirone":[6],"and":[7,22,74,95,121],"midazolam":[8],"(established":[9],"in":[10,25,30,32,47,105,135],"the":[11,26,48,65,71,76,86,103,130,136],"conditioned":[12,49],"fear":[13,50],"test)":[14],"on":[15],"extracellular":[16,87],"concentrations":[17],"glutamate,":[19],"GABA,":[20],"serotonin":[21],"dopamine":[23,90],"metabolites":[24],"hippocampus":[27],"were":[28],"examined":[29],"vivo,":[31],"freely":[33],"moving":[34],"rats.":[35],"Buspirone":[36,83],"at":[37],"a":[38],"dose":[39],"1.5":[41],"mg/kg":[42,59],"ip":[43],"disinhibited":[44],"rat":[45,116],"behavior":[46,118],"test":[51],"(a":[52],"freezing":[53],"response)":[54],"much":[55],"stronger":[56],"than":[57],"1.0":[58],"midazolam.":[61],"Both":[62],"drugs":[63],"enhanced":[64],"local":[66],"concentration":[67,77],"glutamate":[69,107],"to":[70],"similar":[72],"extent,":[73],"decreased":[75],"5-hydroxyindole":[79],"acetic":[80],"acid":[81,93,97],"(5-HIAA).":[82],"increased":[84],"also":[85],"levels":[88],"metabolites:":[91],"homovanillic":[92],"(HVA)":[94],"3,4-dihydroxyphenylacetic":[96],"(DOPAC).":[98],"It":[99],"is":[100],"suggested":[101],"that":[102],"changes":[104],"hippocampal":[106,133],"probably":[108],"are":[109],"not":[110],"directly":[111],"associated":[112],"with":[113],"modification":[114],"emotional":[117],"after":[119],"benzodiazepines":[120],"azapirones.":[122],"present":[124],"results":[125],"provide":[126],"more":[127],"arguments":[128],"for":[129],"role":[131],"5-HT":[134],"drugs.":[140]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}